跳至主要内容
临床试验/NCT02293135
NCT02293135Unknown不适用

Evaluation of the Action of the Stendo Pulsating Suit on Peripheral Microcirculation and on Endothelial Function in Diabetic Patients Without Complication

Stendo1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2014年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
16
试验地点
1
主要终点
Peripheral microcirculation measured using Laser Doppler flowmetry

研究概览

简要总结

The action of one Stendo pulsating suit session will be evaluated on 16 type 2 diabetic patients referred on the diabetic consultations. The effects of one Stendo pulsating suit session system will be assessed on the peripheral cutaneous microcirculation and on endothelial functions

详细描述

The role of the endothelium in micro-vascular system is mediated by synthesis and release of numerous substances that act on the smooth muscle fibers. The release of these products is modulated, in turn, by various circulating molecules, by autonomic nervous system and by local mechanical factors such as shear stress.

The type 2 diabetes leads to early vascular redesign with the onset of endothelial dysfunction and the worsening of the arterial stiffness.

These anomalies, well correlated with the cardiovascular risks, are currently investigated in the department of Endocrinology, Diabetes, and Nutrition at the Jean Verdier Hospital. The analysis methods allow identifying early modifications in response to various drugs, nutritional or physical stimuli.

The aim of this study is therefore to evidence a peripheral microcirculation and endothelial function improvement in type 2 diabetic patient in comparison to a cross-over control session.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Type 2 diabetic patient
  • •Diagnosis of diabetes > 1 year
  • •HBA1c between 6 and 8,5
  • •Treated with oral anti-diabetic, insulin and/or incretins which can be stayed unchanged during the 2-week study

排除标准

  • •Type 1 diabetic Patient
  • •Antecedent of cardiomyopathy, cardiac ischemia or valvulopathy
  • •Severe kidney failure
  • •Non controlled hypertension (> 160/100mm Hg)
  • •Cardiac arrhythmia
  • •Severe respiratory failure
  • •Patient with an advanced obstructive arterial disease
  • •Patient with a recent and progressive deep venous thrombosis

研究组 & 干预措施

Group 1

Experimental

Verum Stendo session on V1 and Phantom Stendo session on V2

干预措施: Verum Stendo session on V1 and Phantom Stendo session on V2 (Device)

Group 2

Experimental

Phantom Stendo session on V1 and Verum Stendo session on V2

干预措施: Phantom Stendo session on V1 and Verum Stendo session on V2 (Device)

结局指标

主要结局

Peripheral microcirculation measured using Laser Doppler flowmetry

时间窗: 30 minutes after the end of the Stendo session

Change in % of the peripheral cutaneous microcirculation using laser Doppler flowmetry after one Stendo pulsating suit session

次要结局

  • Heart Rate Variability (HRV)(15 minutes after the end of Stendo session)
  • Endothelium-dependant microvascular flow after local acetylcholine iontophoresis(35 minutes after the end of Stendo session)
  • Arterial stiffness(10 minutes after the end of Stendo session)
  • Reactive Hyperemia Index (RHI)(45 minutes after the end of Stendo session)

研究者

发起方
Stendo
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验